Peter Sleight, MD FACC
Professor Peter Sleight is currently Honorary Consultant Physician at the Oxford Radcliffe NHS Trust (since 1964), Emeritus Professor of Cardiovascular Medicine University of Oxford, and Emeritus Fellow Exeter College, Oxford.
Professor Sleight was formerly President of the World Hypertension League and serves as chair of the ISIS group steering committee and the related coronary prevention studies coordinated by the Clinical Trials Service Unit in Oxford.
He retired from the BHF-sponsored Oxford University Field Marshal Alexander Chair of Cardiovascular Medicine in 1994.
is the recipient of awards, including the
Professor Sleight is a Fellow of the American College of Cardiology and has served on the editorial board for many cardiology journals, including: Cardiovascular Research, Cardiovascular Risk, Circulation, Hypertension, the British Heart Journal, Clinical & Experimental Physiology & Pharmacology, and the Journal of Ambulatory Monitoring.
has published over 400 original scientific papers in such journals as The Lancet, New England Journal of Medicine, Circulation, Heart
, European Heart Journal
, the British Medical Journal and Clinical Science
on a wide variety of topics, including:
remains an active contributor to the field of cardiology.
As chair of the ISIS group steering committee he has been involved in international trials in cardiology, such as the use of Aspirin (ISIS-2), Thrombolysis (ISIS 2&3), ACE Inhibitors (HOPE) and Statins (HPS).
He has served or continues to serve on several data monitoring committees of major clinical trials, including Gusto, ECLA, CREATE, OASIS 5-7, COMMIT, VALUE, PACE, SCOUT, ORIGIN, GISSI-HF, RELY, CURRENT,and PrOFESS.